Skip to main content
FinSpry Logo
FinSpry
LXRX logo
LXRX
(NASDAQ)
Lexicon Pharmaceuticals, Inc.
$1.59-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lexicon Pharmaceuticals (LXRX) Stock Price & Financial Analysis

Lexicon Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.58 - $1.63
52-Week High$1.83
52-Week Low$0.36
Open$1.61
Volume2.31M
Average Volume (3M)2.31M
Market Cap577.25M
Shares Outstanding363.05M
Price to Sales (P/S)11.96
Price to Book (P/B)5.54
EV/EBITDA-14.61
Revenue (TTM)49.80M
Net Income (TTM)-50.34M
EPS (TTM)$-0.14
Profit Margin-101.08%
Operating Margin-98.21%
Return on Equity (ROE)-46.81%
Debt to Equity0.58
50-Day MA$1.52
200-Day MA$1.29
52-Week Change253.37%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lexicon Pharmaceuticals

What is the current stock price for LXRX?

As of the latest trading session, LXRX stock trades at $1.59. The 52-week range is $0.36–$1.83, with a day range of $1.58–$1.63.

What is the P/E ratio for LXRX?

The P/E ratio (Price-to-Earnings) for LXRX is shown in the Key Statistics section. This valuation metric helps compare Lexicon Pharmaceuticals, Inc. to industry peers.

Does LXRX pay dividends?

Lexicon Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LXRX?

Based on 2 analysts, the consensus for LXRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LXRX?

Lexicon Pharmaceuticals's market capitalization is $577.3M, classifying it as a small-cap company. Lexicon Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.